Abstract
In response to changing market pressures, academic medical centers have adopted a variety of coping strategies. In 1989 Ralph Snyderman became chancellor for health affairs and dean of the Duke University School of Medicine. Snyderman came to Duke after two years in senior leadership positions at Genentech Inc., and immediately utilized his strong understanding of the private sector to build several innovative programs at Duke.
Under his aegis, Duke has worked to set up its own HMO, serve as a major center for clinical trials, and pioneered at times tumultuous efforts to “right-size” its academic programs.
Interviewed in his office on the plush grounds of Duke University, Snyderman discussed the future relationship of industry and academia, the economics of medical care reimbursement, and the implications of those changes on graduate medical education.
Get full access to this article
View all access options for this article.